2 Materials and methods 2.1 Study design This study was a multi-center, prospective, double-blind, randomized clinical trial aimed to assess the absorption rate and hence bioavailibility of an innovative oral Sucrosomial B12 (Sidevit B12 developed by Pharmanutra S.p.A, Pisa, Italy) in enhancing circulatory B12 levels in healthy deficient adults, compared to various conventional oral B12 supplement formulations, selected randomly from local pharmacies at each participating center
Safety & Contraindications GLOW and its component peptides are not FDA-approved drugs
Symptoms : In addition to knee pain, rheumatoid arthritis may produce morning stiffness and pain in other joints
Transport to the small intestine: Vitamin B12 is transferred from the transport protein to the intrinsic factor
What to Expect During Treatment Consultation & Health Assessment We begin with a comprehensive medical history review, assess prior weight loss efforts, and may include laboratory work